Jipan Xie

Jipan Xie


Ph.D., health policy and administration, University of North Carolina at Chapel Hill; M.D., Peking Union Medical College

Summary of Experience

Dr. Xie is a health economist with extensive experience in health economics and outcomes research (HEOR). Her expertise includes economic evaluations, health technology assessments (HTAs) in both US and global markets, and comparative outcomes research using clinical trial and real-world data. Dr. Xie has worked in a variety of disease areas, including mental health, oncology, cardiovascular and other chronic diseases, and infectious diseases. Her work has been widely published in leading clinical, economic, and managed care journals such as Circulation, Stroke, PharmacoEconomics, Value in Health, and The American Journal of Managed Care. Dr. Xie has extensive experience in emerging markets, particularly in China. Her work in this area includes outcomes research using high-quality electronic medial record (EMR) data, economic evaluations, market access of oncology drugs, burden of illness based on claims and surveys, and the China National Stroke Registry design and revision of the treatment guidelines for hypertension and diabetes. She coedited a special issue on health care in China for PharmacoEconomics. Prior to joining Analysis Group, Dr. Xie was a health services researcher at the Centers for Disease Control and Prevention, leading health services and outcomes research in the Division for Heart Disease and Stroke Prevention.

Selected Publishing

Jipan Xie